Antiretroviral Compounds: Mechanisms Underlying Failure of HAART to Eradicate HIV-1

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|15|1705-1719

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.15, 2005-07, pp. : 1705-1719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 rebound after HAART discontinuation examined

By  

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Antiretroviral therapies in HIV-1 infection

By Morris-Jones S.   Moyle G.   Easterbrook P.J.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 8, 1997-08 ,pp. : 1049-1062

Informa Healthcare

Access to resources Recommend Favorite

Computational Analysis of Human Immunodeficiency Virus (HIV) Type-1 Reverse Transcriptase Crystallographic Models Based on Significant Conserved Residues Found in Highly Active Antiretroviral Therapy (HAART)-Treated Patients (Supplementary Material)

By  

Current Medicinal Chemistry, Vol. 17, Iss. 4, 2010-02 ,pp. : 290-308

Bentham Science Publishers

Access to resources Recommend Favorite

Nevirapine-based HAART is more effective than protease inhibitor (PI)-based HAART in antiretroviral therapy-naive pregnant women with HIV infection

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs

By  

Current Drug Targets, Vol. 12, Iss. 3, 2011-01 ,pp. : 348-356

Bentham Science Publishers

Access to resources Recommend Favorite